ArticleCancer immunology, immunotherapy : CII2015

Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.

Zhitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.